| Windlas Biotech Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Particulars | Mar '2025 | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 |
|---|---|---|---|---|---|
| Debt-Equity Ratio | 0.04 | 0.01 | 0.01 | 0.07 | 0.14 |
| Long Term Debt-Equity Ratio | 0.00 | 0.01 | 0.00 | 0.00 | 0.01 |
| Current Ratio | 1.33 | 1.73 | 2.63 | 2.60 | 1.46 |
| Fixed Assets | 2.45 | 2.70 | 2.87 | 2.90 | 2.87 |
| Inventory | 10.59 | 9.22 | 7.69 | 9.30 | 9.42 |
| Debtors | 5.01 | 4.99 | 4.51 | 4.90 | 5.94 |
| Interest Cover Ratio | 19.13 | 71.02 | 73.22 | 33.42 | 34.74 |
| PBIDTM (%) | 14.71 | 14.51 | 13.68 | 12.79 | 13.51 |
| PBITM (%) | 11.02 | 12.38 | 11.28 | 10.18 | 10.48 |
| PBDTM (%) | 14.13 | 14.34 | 13.53 | 12.49 | 13.21 |
| CPM (%) | 11.66 | 11.34 | 10.72 | 10.88 | 7.59 |
| APATM (%) | 7.98 | 9.21 | 8.31 | 8.28 | 4.56 |
| ROCE (%) | 16.79 | 18.03 | 14.22 | 14.91 | 18.75 |
| RONW (%) | 12.69 | 13.63 | 10.69 | 12.98 | 9.39 |